Interestingly, cytokines are among the emerging diagnostic and prognostic biomarkers in CCA [27], and IL-6, IL-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been found to be increased in CCA patients [28]. This evidence concerns the gene IL6 and cholangiocarcinoma.